Log In
Print this Print this

Biosimilar trastuzumab, trastuzumab

  Manage Alerts
Collapse Summary General Information
Company BioXpress Therapeutics S.A.
DescriptionBiosimilar of trastuzumab
Molecular Target
Mechanism of ActionBiosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today